Literature DB >> 30355165

Interdisciplinary Stem Cell Institute at the University of Miami Miller School of Medicine.

Ivonne Hernandez Schulman1, Aisha Khan1, Joshua M Hare1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30355165      PMCID： PMC6289183          DOI： 10.1161/CIRCRESAHA.118.310426

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  17 in total

1.  Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting: The Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS) trial.

Authors:  Vasileios Karantalis; Darcy L DiFede; Gary Gerstenblith; Si Pham; James Symes; Juan Pablo Zambrano; Joel Fishman; Pradip Pattany; Ian McNiece; John Conte; Steven Schulman; Katherine Wu; Ashish Shah; Elayne Breton; Janice Davis-Sproul; Richard Schwarz; Gary Feigenbaum; Muzammil Mushtaq; Viky Y Suncion; Albert C Lardo; Ivan Borrello; Adam Mendizabal; Tomer Z Karas; John Byrnes; Maureen Lowery; Alan W Heldman; Joshua M Hare
Journal:  Circ Res       Date:  2014-02-24       Impact factor: 17.367

Review 2.  Mesenchymal Stem Cell-Based Therapy for Cardiovascular Disease: Progress and Challenges.

Authors:  Luiza Bagno; Konstantinos E Hatzistergos; Wayne Balkan; Joshua M Hare
Journal:  Mol Ther       Date:  2018-05-25       Impact factor: 11.454

3.  Allogeneic Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis via Intravenous Delivery (AETHER): A Phase I Safety Clinical Trial.

Authors:  Marilyn K Glassberg; Julia Minkiewicz; Rebecca L Toonkel; Emmanuelle S Simonet; Gustavo A Rubio; Darcy DiFede; Shirin Shafazand; Aisha Khan; Marietsy V Pujol; Vincent F LaRussa; Lisa H Lancaster; Glenn D Rosen; Joel Fishman; Yolanda N Mageto; Adam Mendizabal; Joshua M Hare
Journal:  Chest       Date:  2016-11-24       Impact factor: 9.410

4.  Randomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy: POSEIDON-DCM Trial.

Authors:  Joshua M Hare; Darcy L DiFede; Angela C Rieger; Victoria Florea; Ana M Landin; Jill El-Khorazaty; Aisha Khan; Muzammil Mushtaq; Maureen H Lowery; John J Byrnes; Robert C Hendel; Mauricio G Cohen; Carlos E Alfonso; Krystalenia Valasaki; Marietsy V Pujol; Samuel Golpanian; Eduard Ghersin; Joel E Fishman; Pradip Pattany; Samirah A Gomes; Cindy Delgado; Roberto Miki; Fouad Abuzeid; Mayra Vidro-Casiano; Courtney Premer; Audrey Medina; Valeria Porras; Konstantinos E Hatzistergos; Erica Anderson; Adam Mendizabal; Raul Mitrani; Alan W Heldman
Journal:  J Am Coll Cardiol       Date:  2016-11-14       Impact factor: 24.094

5.  First human experience with autologous Schwann cells to supplement sciatic nerve repair: report of 2 cases with long-term follow-up.

Authors:  Zachary C Gersey; S Shelby Burks; Kim D Anderson; Marine Dididze; Aisha Khan; W Dalton Dietrich; Allan D Levi
Journal:  Neurosurg Focus       Date:  2017-03       Impact factor: 4.047

6.  Safety of Autologous Human Schwann Cell Transplantation in Subacute Thoracic Spinal Cord Injury.

Authors:  Kim D Anderson; James D Guest; W Dalton Dietrich; Mary Bartlett Bunge; Rosie Curiel; Marine Dididze; Barth A Green; Aisha Khan; Damien D Pearse; Efrat Saraf-Lavi; Eva Widerström-Noga; Patrick Wood; Allan D Levi
Journal:  J Neurotrauma       Date:  2017-03-21       Impact factor: 5.269

7.  Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial.

Authors:  Alan W Heldman; Darcy L DiFede; Joel E Fishman; Juan P Zambrano; Barry H Trachtenberg; Vasileios Karantalis; Muzammil Mushtaq; Adam R Williams; Viky Y Suncion; Ian K McNiece; Eduard Ghersin; Victor Soto; Gustavo Lopera; Roberto Miki; Howard Willens; Robert Hendel; Raul Mitrani; Pradip Pattany; Gary Feigenbaum; Behzad Oskouei; John Byrnes; Maureen H Lowery; Julio Sierra; Mariesty V Pujol; Cindy Delgado; Phillip J Gonzalez; Jose E Rodriguez; Luiza Lima Bagno; Didier Rouy; Peter Altman; Cheryl Wong Po Foo; Jose da Silva; Erica Anderson; Richard Schwarz; Adam Mendizabal; Joshua M Hare
Journal:  JAMA       Date:  2014-01-01       Impact factor: 56.272

8.  Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty.

Authors:  Samuel Golpanian; Darcy L DiFede; Aisha Khan; Ivonne Hernandez Schulman; Ana Marie Landin; Bryon A Tompkins; Alan W Heldman; Roberto Miki; Bradley J Goldstein; Muzammil Mushtaq; Silvina Levis-Dusseau; John J Byrnes; Maureen Lowery; Makoto Natsumeda; Cindy Delgado; Russell Saltzman; Mayra Vidro-Casiano; Marietsy V Pujol; Moisaniel Da Fonseca; Anthony A Oliva; Geoff Green; Courtney Premer; Audrey Medina; Krystalenia Valasaki; Victoria Florea; Erica Anderson; Jill El-Khorazaty; Adam Mendizabal; Pascal J Goldschmidt-Clermont; Joshua M Hare
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2017-10-12       Impact factor: 6.053

9.  Dose Comparison Study of Allogeneic Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy (The TRIDENT Study).

Authors:  Victoria Florea; Angela C Rieger; Darcy L DiFede; Jill El-Khorazaty; Makoto Natsumeda; Monisha N Banerjee; Bryon A Tompkins; Aisha Khan; Ivonne H Schulman; Ana Marie Landin; Muzammil Mushtaq; Samuel Golpanian; Maureen H Lowery; John J Byrnes; Robert C Hendel; Mauricio G Cohen; Krystalenia Valasaki; Marietsy V Pujol; Eduard Ghersin; Roberto Miki; Cindy Delgado; Fouad Abuzeid; Mayra Vidro-Casiano; Russell G Saltzman; Daniel DaFonseca; Lina V Caceres; Kevin N Ramdas; Adam Mendizabal; Alan W Heldman; Raul D Mitrani; Joshua M Hare
Journal:  Circ Res       Date:  2017-09-18       Impact factor: 17.367

10.  Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

Authors:  Bryon A Tompkins; Darcy L DiFede; Aisha Khan; Ana Marie Landin; Ivonne Hernandez Schulman; Marietsy V Pujol; Alan W Heldman; Roberto Miki; Pascal J Goldschmidt-Clermont; Bradley J Goldstein; Muzammil Mushtaq; Silvina Levis-Dusseau; John J Byrnes; Maureen Lowery; Makoto Natsumeda; Cindy Delgado; Russell Saltzman; Mayra Vidro-Casiano; Moisaniel Da Fonseca; Samuel Golpanian; Courtney Premer; Audrey Medina; Krystalenia Valasaki; Victoria Florea; Erica Anderson; Jill El-Khorazaty; Adam Mendizabal; Geoff Green; Anthony A Oliva; Joshua M Hare
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2017-10-12       Impact factor: 6.053
View more
  2 in total

1.  Demographic representation in clinical trials for cell-based therapy.

Authors:  Russell G Saltzman; Dushyantha T Jayaweera; Lina V Caceres; Jairo A Tovar; Mayra Vidro-Casiano; Vela Karakeshishyan; Jeanette Soto; Aisha Khan; Raul D Mitrani; Ivonne H Schulman; Joshua M Hare
Journal:  Contemp Clin Trials Commun       Date:  2021-01-07

Review 2.  The National Heart, Lung, and Blood Institute-funded Production Assistance for Cellular Therapies (PACT) program: Eighteen years of cell therapy.

Authors:  Ashraf El Fiky; Laarni Ibenana; Robert Anderson; Joshua M Hare; Aisha Khan; Adrian P Gee; Cliona Rooney; David H McKenna; Joseph Gold; Linda Kelley; Martha S Lundberg; Lisbeth A Welniak; Robert Lindblad
Journal:  Clin Transl Sci       Date:  2021-07-19       Impact factor: 4.689
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.